Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonist.

Saved in:
Bibliographic Details
Title: Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonist.
Authors: Gunnet JW; Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, NJ 08869, USA. jgunnet@prdus.jnj.com, Matthews JM, Maryanoff BE, de Garavilla L, Andrade-Gordon P, Damiano B, Hageman W, Look R, Stahle P, Streeter AJ, Wines PG, Demarest KT
Source: Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2006 Apr; Vol. 33 (4), pp. 320-6.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0425076 Publication Model: Print Cited Medium: Print ISSN: 0305-1870 (Print) Linking ISSN: 03051870 NLM ISO Abbreviation: Clin Exp Pharmacol Physiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0305-1870
DOI:10.1111/j.1440-1681.2006.04369.x